Detalhe da pesquisa
1.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Clin Transl Oncol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361134